Demographic and clinical data in patients with MOH
| Responders (N = 11) | Nonresponders (N = 11) | p valuea | |
|---|---|---|---|
| Time between scans (d) | 113.2 ± 42.6 | 107.3 ± 32.3 | 0.720 (t test) |
| Age (years) | 41.8 ± 9.1 | 44.3 ± 12.0 | 0.365 |
| Gender (female/male) | 9/2 | 9/2 | NA |
| Headache | |||
| d/month at baseline | 25.0 ± 6.8 | 26.2 ± 5.3 | 0.652 |
| % reduction | 73.4 ± 10.1 | 18.7 ± 27.5 | <0.001 |
| Receiving medication | |||
| d/month at follow-up | 6.4 ± 4.9 | 12.8 ± 9.4 | 0.047 |
| Δd/month at follow-up | −14.2 ± 8.7 | −10.4 ± 10.8 | 0.300 |
| Headache duration (years) | 20.1 ± 12.2 | 19.0 ± 10.0 | 1.000 |
| HADS-A (baseline) | 8.5 ± 4.2 | 8.3 ± 3.6 | 0.898 |
| HADS-D (baseline) | 7.9 ± 6.3 | 6.9 ± 5.0 | 0.699 |
HADS, Hospital Anxiety and Depression Scale; HADS-A, anxiety subscale; HADS-D, depression subscale; NA, not applicable.
↵aMann–Whitney U test, unless otherwise indicated.